FI955304L - (1,2,4)triatsoli(4,3-a)kinoksaliiniyhdisteitä, niiden valmistus ja käyttö - Google Patents

(1,2,4)triatsoli(4,3-a)kinoksaliiniyhdisteitä, niiden valmistus ja käyttö Download PDF

Info

Publication number
FI955304L
FI955304L FI955304A FI955304A FI955304L FI 955304 L FI955304 L FI 955304L FI 955304 A FI955304 A FI 955304A FI 955304 A FI955304 A FI 955304A FI 955304 L FI955304 L FI 955304L
Authority
FI
Finland
Prior art keywords
triazolo
preparation
quinoxaline compounds
quinoxaline
compounds
Prior art date
Application number
FI955304A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955304A0 (fi
FI955304A7 (fi
Inventor
Poul Jacobsen
Flemming Elmelund Nielsen
Lone Jeppesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK53593A external-priority patent/DK53593D0/da
Priority claimed from DK128793A external-priority patent/DK128793D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI955304A0 publication Critical patent/FI955304A0/fi
Publication of FI955304A7 publication Critical patent/FI955304A7/fi
Publication of FI955304L publication Critical patent/FI955304L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI955304A 1993-05-06 1994-04-28 (1,2,4)triatsoli(4,3-a)kinoksaliiniyhdisteitä, niiden valmistus ja käyttö FI955304L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK53593A DK53593D0 (da) 1993-05-06 1993-05-06 Oe1,2,4aatriazolooe4,3-aaaquinoxalinonforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK128793A DK128793D0 (de) 1993-11-12 1993-11-12
PCT/DK1994/000170 WO1994026746A1 (en) 1993-05-06 1994-04-28 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE

Publications (3)

Publication Number Publication Date
FI955304A0 FI955304A0 (fi) 1995-11-06
FI955304A7 FI955304A7 (fi) 1995-11-06
FI955304L true FI955304L (fi) 1995-11-06

Family

ID=26064177

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955304A FI955304L (fi) 1993-05-06 1994-04-28 (1,2,4)triatsoli(4,3-a)kinoksaliiniyhdisteitä, niiden valmistus ja käyttö

Country Status (19)

Country Link
US (1) US5532236A (de)
EP (1) EP0698024B1 (de)
JP (1) JPH08509747A (de)
KR (1) KR100304177B1 (de)
CN (1) CN1041931C (de)
AT (1) ATE148120T1 (de)
AU (1) AU683062B2 (de)
CA (1) CA2162023A1 (de)
DE (1) DE69401583T2 (de)
DK (1) DK0698024T3 (de)
ES (1) ES2097652T3 (de)
FI (1) FI955304L (de)
GR (1) GR3023001T3 (de)
HU (1) HUT73983A (de)
IL (1) IL109530A (de)
NO (1) NO305516B1 (de)
NZ (1) NZ266127A (de)
TW (1) TW377354B (de)
WO (1) WO1994026746A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996008493A1 (en) * 1994-09-16 1996-03-21 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
EP0783504B1 (de) * 1994-09-16 2000-03-15 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]CHINOXYLINONDERIVATE, IHRE DARSTELLUNG UND VERWENDUNG ALS ANTAGONISTEN VON AMPA-REZEPTOREN
DE19510965A1 (de) * 1995-03-24 1996-09-26 Asta Medica Ag Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
BR9709085A (pt) 1996-05-15 1999-08-03 Pfizer Novas 2,3-dissubstituído-4(3H)-quinazolinonas
WO1998027097A1 (en) * 1996-12-16 1998-06-25 Warner-Lambert Company Tricyclic quinoxaline derivatives as neuroprotective agents
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
US6323208B1 (en) 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
CA2310072A1 (en) 1997-11-11 1999-05-20 Hiroyuki Ohno Fused pyrazine compounds
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP2338492A1 (de) 2009-12-24 2011-06-29 Universidad del Pais Vasco Verfahren und Zusammensetzung zur Behandlung von Alzheimer
WO2016199943A1 (en) * 2015-06-11 2016-12-15 Takeda Pharmaceutical Company Limited Heterocyclic compounds
HRP20221020T1 (hr) * 2018-07-20 2022-11-11 Grünenthal GmbH Supstituirani derivati triazolo kinoksalina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400382A (en) * 1980-05-09 1983-08-23 Usv Pharmaceutical Corporation Thiazoloquinoxalin-1,4-diones for treating allergy
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne

Also Published As

Publication number Publication date
EP0698024A1 (de) 1996-02-28
US5532236A (en) 1996-07-02
KR960701877A (ko) 1996-03-28
NO305516B1 (no) 1999-06-14
AU683062B2 (en) 1997-10-30
EP0698024B1 (de) 1997-01-22
JPH08509747A (ja) 1996-10-15
WO1994026746A1 (en) 1994-11-24
CN1041931C (zh) 1999-02-03
AU6720094A (en) 1994-12-12
FI955304A0 (fi) 1995-11-06
GR3023001T3 (en) 1997-07-30
NO954402D0 (no) 1995-11-03
DE69401583D1 (de) 1997-03-06
CN1125446A (zh) 1996-06-26
ATE148120T1 (de) 1997-02-15
NO954402L (no) 1996-01-05
ES2097652T3 (es) 1997-04-01
IL109530A0 (en) 1994-08-26
NZ266127A (en) 1997-11-24
IL109530A (en) 1997-01-10
TW377354B (en) 1999-12-21
KR100304177B1 (ko) 2001-11-22
FI955304A7 (fi) 1995-11-06
DK0698024T3 (da) 1997-07-28
CA2162023A1 (en) 1994-11-24
DE69401583T2 (de) 1997-06-12
HUT73983A (en) 1996-10-28
HU9503157D0 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
FI971225L (fi) Pyrrolo(2,3-d)pyrimidiinit ja niiden käyttö
FI952179A7 (fi) Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus
MX9202838A (es) Imidazo[1,5-a]quinoxalinas.
FI945281A7 (fi) Heterosykliset yhdisteet, niiden valmistus ja käyttö
FI941378L (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
FI961219A7 (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
DE69529777D1 (de) 2-Benzylthio-8-amino(1,2,4)triazolo(1,5-a)pyridine
ITMI922995A0 (it) Granulati di coloranti scorrevoli chimicamente resistenti loro preparazione e loro impiego
FI954386A0 (fi) (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö
FI955304A7 (fi) (1,2,4)triatsoli(4,3-a)kinoksaliiniyhdisteitä, niiden valmistus ja käy ttö
FI944417A7 (fi) Atsoliyhdisteet, niiden valmistus ja käyttö
ZA927172B (en) Heterocyclic compounds and their preparation and use.
FI20030361L (fi) Perhydro-1H-pyrido[1,2-a]pyratsiinijohdannaiset
FI930716A7 (fi) Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
FI954229L (fi) Heterosykliset yhdisteet, niiden käyttö ja valmistus
FI944933A7 (fi) 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sit ä sisältäviä farmaseuttisia käyttöjä ja koostumuksia
FI923290L (fi) Imidazo(2,1-b)bensotiazol-3-acetamidderivat
FI943294L (fi) Alkaloidit Mappia foetidasta, niiden käyttö, ja niitä sisältävät formulloinnit
EP0511152A3 (en) Quinoxaline compounds, their preparation and use
FI971075L (fi) (1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
DE69516467D1 (de) Feste Lösungen von Pyrrolo-(3,4-c)-pyrrolen mit Chinacridonchinonen
FI971076L (fi) (1,2,4)triatsolo (4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
ZA939760B (en) 2-Thienylimidazo(2,1-b)benzothiazole-3-acetic acid derivatives their preparation and their use
ZA943114B (en) [1,2,4]Triazolo[4,3-a]quinoxaline compounds their preparation and use
AU2141595A (en) 1,2,4-triazolo{4,3-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same